Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GONAL-f endometrial gene expression profiling in IVF
2007-003938-41Phase 4Completed
- Sponsor
- Merck Santé
- Start
- Aug 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of follitropin alfa in female infertility, sponsored by Merck Santé. Primary endpoints: Differential endometrial gene expression after GONAL-f cycle, Histologic changes in endometrial tissue after GONAL-f cycle and 1 more. Started Aug 2007; status: completed.
02
Drugs
follitropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on 2007-003938-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003938-41.